NCT07644832: An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 76 planned
- Started
- 31 May 2024
- Primary completion
- 31 Dec 2026
- Arms
- Part A: Dose escalation trial consists of 6 cohorts, Part B: Multiple-dose exploratory efficacy trial consists of 2 cohorts, Part C: Multiple-dose exploratory efficacy trial consists of 3 cohorts
- Results
- None posted
- 31 May 2024: Trial started
- 12 Jun 2026: Trial registered